{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:28:20Z","timestamp":1791685700217,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bmc.2019.115155","type":"journal-article","created":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T17:57:59Z","timestamp":1573322279000},"page":"115155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity"],"prefix":"10.1016","volume":"28","author":[{"given":"Devika","family":"Rana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.","family":"Kalamuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Sundriyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koushik","family":"Das Sarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puran Singh","family":"Sijwali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Mohmmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Mahindroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2019.115155_b0005","unstructured":"World Malaria Report 2018. World Health Organization. Geneva; 2018."},{"key":"10.1016\/j.bmc.2019.115155_b0010","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: a glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2019.115155_b0015","unstructured":"Antimalarial Drug Combination Therapy: Report of a WHO Technical Consultation: 4-5 April 2001, World Health Organization; 2001."},{"key":"10.1016\/j.bmc.2019.115155_b0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1016\/j.bmc.2019.115155_b0025","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2174\/092986706776055733","article-title":"Thiol proteases: inhibitors and potential therapeutic targets","volume":"13","author":"Leung-Toung","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2019.115155_b0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0968-0896(99)00008-5","article-title":"Cysteine protease inhibitors as chemotherapy for parasitic infections","volume":"7","author":"McKerrow","year":"1999","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2019.115155_b0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0163-7258(98)00036-9","article-title":"An overview of chemotherapeutic targets for antimalarial drug discovery","volume":"81","author":"Olliaro","year":"1999","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmc.2019.115155_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006512","article-title":"Cysteine proteases in protozoan parasites","volume":"12","author":"Siqueira-Neto","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2019.115155_b0045","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/092986711795328328","article-title":"Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria","volume":"18","author":"Teixeira","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2019.115155_b0050","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1242\/jeb.00589","article-title":"Antimalarial drug discovery: old and new approaches","volume":"206","author":"Rosenthal","year":"2003","journal-title":"J Exp Biol"},{"key":"10.1016\/j.bmc.2019.115155_b0055","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2174\/1381612023394197","article-title":"Cysteine proteases of malaria parasites: targets for chemotherapy","volume":"8","author":"Rosenthal","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmc.2019.115155_b0060","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2174\/156802612799362913","article-title":"Falcipain inhibition as a promising antimalarial target","volume":"12","author":"Marco","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2019.115155_b0065","doi-asserted-by":"crossref","first-page":"8721","DOI":"10.1073\/pnas.0402738101","article-title":"Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites","volume":"101","author":"Sijwali","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2019.115155_b0070","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molbiopara.2006.06.013","article-title":"Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum","volume":"150","author":"Sijwali","year":"2006","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2019.115155_b0075","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1182\/blood-2002-01-0101","volume":"100","author":"Hanspal","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2019.115155_b0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molbiopara.2004.11.009","article-title":"Biosynthesis, localization, and processing of falcipain cysteine proteases of Plasmodium falciparum","volume":"139","author":"Dahl","year":"2005","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmc.2019.115155_b0085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1110\/ps.0228103","article-title":"Probing the structure of falcipain-3, a cysteine protease from Plasmodium falciparum: Comparative protein modeling and docking studies","volume":"12","author":"Sabnis","year":"2003","journal-title":"Protein Sci"},{"key":"10.1016\/j.bmc.2019.115155_b0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/AAC.47.1.154-160.2003","article-title":"Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones","volume":"47","author":"Shenai","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.115155_b0095","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1021\/jm501439w","article-title":"Synthesis of gallinamide a analogues as potent falcipain inhibitors and antimalarials","volume":"57","author":"Conroy","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.115155_b0100","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/ci2005516","article-title":"Computer-aided drug design of falcipain inhibitors: virtual screening, structure-activity relationships, hydration site thermodynamics, and reactivity analysis","volume":"52","author":"Shah","year":"2012","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2019.115155_b0105","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1080\/07391102.2015.1108231","article-title":"Analysis of non-peptidic compounds as potential malarial inhibitors against Plasmodial cysteine proteases via integrated virtual screening workflow","volume":"34","author":"Musyoka","year":"2016","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2019.115155_b0110","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1021\/jm801622x","article-title":"Identification of novel falcipain-2 inhibitors as potential antimalarial agents through structure-based virtual screening","volume":"52","author":"Li","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.115155_b0115","article-title":"Design, synthesis and evaluation of 2-(4-(substituted benzoyl)-1,4-diazepan-1-yl)-N-phenylacetamide derivatives as a new class of falcipain-2 inhibitors","author":"Mahesh","year":"2014","journal-title":"Arab J Chem"},{"key":"10.1016\/j.bmc.2019.115155_b0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1021\/acsinfecdis.5b00093","article-title":"Computer-aided drug discovery approaches against the tropical infectious diseases malaria, tuberculosis, trypanosomiasis, and leishmaniasis","volume":"2","author":"Njogu","year":"2015","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2019.115155_b0125","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","article-title":"Structure-based virtual screening for drug discovery: principles, applications and recent advances","volume":"14","author":"Lionta","year":"2014","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2019.115155_b0130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1517\/17460441.3.8.841","article-title":"What has virtual screening ever done for drug discovery?","volume":"3","author":"Clark","year":"2008","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmc.2019.115155_b0135","doi-asserted-by":"crossref","first-page":"25697","DOI":"10.1074\/jbc.M109.014340","article-title":"Vinyl sulfones as antiparasitic agents and a structural basis for drug design","volume":"284","author":"Kerr","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2019.115155_b0140","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/jm8013663","article-title":"Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity","volume":"52","author":"Kerr","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.115155_b0145","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera-a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2019.115155_b0150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng Des Sel"},{"key":"10.1016\/j.bmc.2019.115155_b0155","doi-asserted-by":"crossref","first-page":"W409","DOI":"10.1093\/nar\/gks378","article-title":"ZINCPharmer: pharmacophore search of the ZINC database","volume":"40","author":"Koes","year":"2012","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.bmc.2019.115155_b0160","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC: a free tool to discover chemistry for biology","volume":"52","author":"Irwin","year":"2012","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2019.115155_b0165","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1517\/17460441.2010.484460","article-title":"Virtual screening with AutoDock: theory and practice","volume":"5","author":"Cosconati","year":"2010","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmc.2019.115155_b0170","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.115155_b0175","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/minf.201100076","article-title":"KNIME workflow to assess PAINS filters in SMARTS format. Comparison of RDKit and Indigo cheminformatics libraries","volume":"30","author":"Saubern","year":"2011","journal-title":"Mol Inform"},{"key":"10.1016\/j.bmc.2019.115155_b0180","doi-asserted-by":"crossref","first-page":"29000","DOI":"10.1074\/jbc.M004459200","article-title":"Characterization of native and recombinant Falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum","volume":"275","author":"Shenai","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2019.115155_b0185","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/iai.63.6.2120-2125.1995","article-title":"Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase","volume":"63","author":"Salas","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.bmc.2019.115155_b0190","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1172\/JCI113766","article-title":"A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum","volume":"82","author":"Rosenthal","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmc.2019.115155_b0195","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/expr.1995.1033","article-title":"Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites","volume":"80","author":"Rosenthal","year":"1995","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.bmc.2019.115155_b0200","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1128\/AAC.40.7.1600","article-title":"Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors","volume":"40","author":"Rosenthal","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.115155_b0205","unstructured":"Homan E, RDKit PAINS 4 https:\/\/www.myexperiment.org\/workflows\/4748.html (Last Accessed July 7, 2019)."},{"key":"10.1016\/j.bmc.2019.115155_b0210","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","author":"Lambros","year":"1979","journal-title":"J Parasitol"},{"key":"10.1016\/j.bmc.2019.115155_b0215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbrc.2004.02.177","article-title":"Exploring the role of putative active site amino acids and pro-region motif of recombinant falcipain-2: a principal hemoglobinase of Plasmodium falciparum","volume":"317","author":"Kumar","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2019.115155_b0220","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619311939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619311939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:04:45Z","timestamp":1760835885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619311939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0968089619311939"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.115155","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.115155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115155"}}